We recommend that you upgrade to the latest version of your browser.

Publications

Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: A prospective total cohort study

Farivar Fathian, Ivana Divkovic, Maria Fagerbakke Strømme, Arnstein Mykletun, Rune A. Kroken, Christoffer A. Bartz-Johannessen, Erik Johnsen

https://doi.org/10.1016/j.bbih.2025.101133

Phenotypic complexities of rare heterozygous neurexin-1 deletions

Michael B Fernando, Yu Fan, Yanchun Zhang, Alex Tokolyi, Aleta N Murphy, Sarah Kammourh, P J Michael Dean , Sadaf Ghorbani, Ryan Onatzevitch, Adriana Pero, Christopher Padilla, Sarah E Williams, Erin K Flaherty, Iya A Prytkov , Lei Cao, David A Knowles , Gang Fang, Paul A Slesinger, Kristen J Brennand 

https://www.nature.com/articles/s41586-025-08864-9

Dynamic convergence of neurodevelopmental disorder risk genes across neurodevelopment. bioRxiv. 2025. The publication is accepted and In Press in the Nature Neuroscience journal.

Garcia MF, Retallick-Townsley K, Pruitt A, Davidson E, Balafkan N, Warrell J, Huang TC, Kibowen A, Chu Z, Dai Y, Fitzpatrick SE, Meng R, Sen A, Cohen S, Livoti O, Khan S, Becker C, E Silva ALT, Liu J, Dossou G, Cheung J, Liu S, Ghorbani S, Deans PJM, Ceciucis M, Emani P, Gao H, Shen H, Gerstein M, Wang Z, Huckins LM, Hoffman EJ, Brennand K. 

doi: 10.1101/2024.08.23.609190

Schizophrenia Risk Mapping and Functional Engineering of the 3D Genome in Three Neuronal Subtypes. bioRxiv. 2023  

Powell SK, Liao W, O'Shea C, Kammourh S, Ghorbani S, Rigat R, Elahi R, Deans PM, Le DJ, Agarwal P, Seow WQ, Wang KC, Akbaraian S, Brennand  

https://doi.org/10.1101/2023.07.17.549339

Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study

Gunnhild E Hoprekstad, Erik Johnsen, Christoffer Bartz-Johannessen, Kristin Bjarke, Petros Drosos, Ole Bernt Fasmer, Kristian Varden Gjerde, Solveig K Reitan, Silje Skrede, Iris E C Sommer, Lena Stabell, Vidar M Steen, Rune A Kroken

Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study - PubMed

 

Last updated 11/17/2025